HRCM
TYRA icon

Hood River Capital Management’s Tyra Biosciences TYRA Stock Holding History

Hood River Capital Management’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.5M Buy
+1,016,775
New +$33.6M 0.24% 109

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JTL
Jupiter Topco LLC New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Hood River Capital Management's TYRA Position: Q2 2026 in Review

Hood River Capital Management opened a new position in Tyra Biosciences (TYRA) in Q2 2026: 1,016,775 shares worth $32.5M. The stake represents 0.24% of the portfolio and ranks #109 among its holdings.

153 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Hood River Capital Management held 1,016,775 shares of Tyra Biosciences worth $32.5M as of Q2 2026.
  • Tyra Biosciences was a new Hood River Capital Management position in Q2 2026.
  • Tyra Biosciences made up 0.24% of Hood River Capital Management's portfolio in Q2 2026, its #109 holding.
  • 153 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Hood River Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.